Communication
Why the misinformation and disinformation bill is binned for good
The Australian Government’s misinformation bill was formally abandoned over the weekend after it failed to secure support in the Senate. […]
MoreCommunication
Australians’ trust in mainstream health media is in crisis
Despite several mainstream media journalists being recognised at the 2024 Excellence in Health Journalism Awards by Rare Cancers and Prospection […]
MoreCommunication
Breaking the chains: Unveiling Australia’s media monopoly crisis
A Senate committee is considering a proposal for a parliamentary commission of inquiry into the Murdoch media empire and media […]
MoreCommunication
Consumers call out wishy-washy sustainability initiatives
Millions of social media conversations uncovered that Aussies are becoming ‘hyper-aware’ of greenwashing. Greenwashing is when a company claims to […]
MoreCommunication
Why over 50% of women in comms and PR roles face roadblocks to career advancement
More than one in two women in communications and public relations roles rate the industry’s commitment to gender equality as […]
MoreCommunication
Calls to ‘plug the gap’ in PR and comms industry
The public relations and communications industry is struggling to meet an increase in demand as vacancies remain unfilled due to low numbers […]
MoreCommunication
CSL the only healthcare company to win Asia Pacific award
CSL, a global biotech leader, is the only healthcare company that has been recognised for excellence in communications within the […]
MoreCommunication
Trends shaping corporate communications landscape in 2022 – Deep dive with Baxter and Johnson & Johnson leaders
Navigating how best to communicate with internal and external stakeholders has been an ongoing challenge for many communications executives since […]
MoreCommunication
Shifts in corporate communications landscape and key trends for 2022 – Deep dive with Sanofi, AbbVie and AstraZeneca leaders
In today’s post-COVID recovery world, the role of corporate communications has evolved to become more visible; a trusted business leader […]
MoreCommunication
Janssen leader awarded Best PR Professional in Asia-Pacific region
The PRWeek Awards Asia celebrates the most outstanding, inspired and successful campaigns, individuals and companies in the Asia-Pacific’s communications industry. […]
MoreRecent Posts in Pharma, MedTech & Biotech
Medicines Australia and AusBiotech CEOs set agenda for the new year
January 16, 2025
in News & Trends - Pharmaceuticals
MTAA and PTA CEOs voice outlook for the year ahead
January 16, 2025
in News & Trends - MedTech & Diagnostics
Boehringer Ingelheim sets sustainability benchmark in NZ
January 16, 2025
in ESG
Scathing report exposes Labor’s mismanagement of the PBS
January 16, 2025
in News & Trends - Pharmaceuticals
TGA gives green light to GSK-acquired Australian drug for bone marrow cancer
January 16, 2025
in News & Trends - Pharmaceuticals
2025 calls for more than just flipping a page on the calendar
January 15, 2025
in News & Trends - Pharmaceuticals
If action isn’t needed now, then when?
December 17, 2024
in News & Trends - Pharmaceuticals
Victoria prioritises health technologies and medical research in economic growth statement
December 12, 2024
in News & Trends - Biotechnology
Follow Us
Partner with us
News & Trends - Pharmaceuticals
Medicines Australia and AusBiotech CEOs set agenda for the new year
Liz de Somer, CEO of Medicines Australia, and Bek Cassidy, CEO of AusBiotech, look back on the key accomplishments of […]
MoreNews & Trends - MedTech & Diagnostics
MTAA and PTA CEOs voice outlook for the year ahead
Ian Burgess, CEO of the Medical Technology Association of Australia (MTAA), and Dean Whiting, CEO of Pathology Technology Australia (PTA), […]
MoreESG
Boehringer Ingelheim sets sustainability benchmark in NZ
Boehringer Ingelheim’s Auckland office has achieved a milestone in sustainability, earning the prestigious 6 Green Star Interiors certification from the […]
MoreNews & Trends - Pharmaceuticals
Scathing report exposes Labor’s mismanagement of the PBS
The Labor Government’s administration of the $19.5 billion Pharmaceutical Benefit Scheme (PBS) has been found to be only “partly effective”. […]
More